QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)
QQQ   352.93 (+1.18%)
AAPL   179.86 (+1.15%)
MSFT   325.58 (+0.68%)
META   265.00 (+0.53%)
GOOGL   122.05 (-0.37%)
AMZN   123.96 (+2.25%)
TSLA   233.49 (+3.97%)
NVDA   387.20 (+3.32%)
NIO   7.76 (+0.00%)
BABA   86.43 (+1.35%)
AMD   121.19 (+2.85%)
T   16.04 (-0.37%)
F   13.57 (-0.15%)
MU   65.30 (-2.62%)
CGC   0.71 (-2.19%)
GE   106.58 (+0.47%)
DIS   92.44 (-0.09%)
AMC   4.73 (+0.00%)
PFE   39.06 (+0.44%)
PYPL   64.39 (+0.55%)
NFLX   405.95 (+1.55%)

GSK (GSK) News Today

$34.71
+0.35 (+1.02%)
(As of 03:10 PM ET)
Compare
Today's Range
$34.37
$34.73
50-Day Range
$33.60
$38.32
52-Week Range
$28.47
$44.75
Volume
1.96 million shs
Average Volume
3.29 million shs
Market Capitalization
$71.07 billion
P/E Ratio
4.19
Dividend Yield
3.92%
Price Target
N/A
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.



GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment

0.56

0.51

Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week

22

7

GSK Articles
Average Week

SourceHeadline
msn.com logoGSK employees to escalate strike action in June -union
msn.com - June 8 at 11:03 AM
MarketBeat logoGSK plc (NYSE:GSK) to Post Q4 2024 Earnings of $0.90 Per Share, Zacks Research Forecasts
americanbankingnews.com - June 8 at 8:32 AM
marketbeat.com logoGSK plc (NYSE:GSK) Shares Sold by Atria Wealth Solutions Inc.
marketbeat.com - June 8 at 5:58 AM
MarketBeat logoGSK plc (NYSE:GSK) Given Average Rating of "Hold" by Brokerages
americanbankingnews.com - June 8 at 3:54 AM
marketwatch.com logoGSK Receives Authorization for RSV Vaccine From European Commission
marketwatch.com - June 7 at 7:36 PM
msn.com logoEU gives final approval for GSK's RSV vaccine
msn.com - June 7 at 7:36 PM
finance.yahoo.com logoGSK's Arexvy Gets the Green Light in Europe: First-Ever RSV Vaccine in Europe for Older Adults
finance.yahoo.com - June 7 at 2:35 PM
seekingalpha.com logoGSK wins EU approval for RSV vaccine Arexvy
seekingalpha.com - June 7 at 9:35 AM
marketbeat.com logoZacks Research Analysts Lift Earnings Estimates for GSK plc (NYSE:GSK)
marketbeat.com - June 7 at 5:57 AM
finance.yahoo.com logoUPDATE 1-EU authorises GSK's RSV vaccine
finance.yahoo.com - June 7 at 4:35 AM
lse.co.uk logoUS FDA accepts GSK's licence application for cancer treatment Jemperli
lse.co.uk - June 6 at 1:33 PM
msn.com logoGSK granted FDA priority review for label expansion in cancer drug Jemperli
msn.com - June 6 at 1:33 PM
finance.yahoo.com logoFDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in Decades
finance.yahoo.com - June 6 at 1:33 PM
marketbeat.com logoFranklin Resources Inc. Has $1.74 Million Stock Holdings in GSK plc (NYSE:GSK)
marketbeat.com - June 6 at 5:48 AM
marketwatch.com logoGSK Gets FDA File Acceptance For Jemperli Endometrial Cancer Treatment
marketwatch.com - June 6 at 3:32 AM
money.usnews.com logoGSK's Cancer Drug Jemperli Gets File Acceptance From US FDA
money.usnews.com - June 6 at 3:32 AM
marketbeat.com logoBank of America Corp DE Decreases Stock Position in GSK plc (NYSE:GSK)
marketbeat.com - June 5 at 6:50 AM
marketbeat.com logoVictory Capital Management Inc. Invests $978,000 in GSK plc (NYSE:GSK)
marketbeat.com - June 4 at 5:12 AM
marketbeat.com logoGSK plc (NYSE:GSK) Shares Sold by Renaissance Technologies LLC
marketbeat.com - June 2 at 1:50 PM
uk.finance.yahoo.com logoDown 12% since April, the GSK share price fall looks overdone to me
uk.finance.yahoo.com - June 1 at 1:42 PM
finance.yahoo.com logoGSK CEO Emma Walmsley says A.I. could improve Big Pharma’s most ‘profound’ challenge: R&D productivity
finance.yahoo.com - June 1 at 8:42 AM
finance.yahoo.com logoGSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US
finance.yahoo.com - June 1 at 8:42 AM
barrons.com logoUS Approves Second RSV Vaccine
barrons.com - May 31 at 10:41 PM
fortune.com logoGSK’s CEO says you need thick skin if you’re going to step into the C-suite
fortune.com - May 31 at 5:40 PM
marketbeat.com logoSei Investments Co. Raises Position in GSK plc (NYSE:GSK)
marketbeat.com - May 29 at 7:37 AM
marketbeat.com logoGSK plc (NYSE:GSK) Stock Position Lowered by Kavar Capital Partners Group LLC
marketbeat.com - May 26 at 1:59 PM
wsj.com logoGucci-Owner Kering, Drugmaker GSK and Others Are Developing Global Targets on Nature Loss
wsj.com - May 25 at 7:37 AM
wsj.com logoGucci-Owner Kering, Drugmaker GSK and Others Are Developing a Global Standard on Nature Loss
wsj.com - May 25 at 7:37 AM
finance.yahoo.com logoMarket Digest: MKL, GSK, NFG
finance.yahoo.com - May 24 at 8:40 AM
thetimes.co.uk logoShare tip: A spoonful of GSK will help your profit go up
thetimes.co.uk - May 20 at 10:34 PM
marketbeat.com logoScotia Capital Inc. Has $2.02 Million Stock Position in GSK plc (NYSE:GSK)
marketbeat.com - May 19 at 7:59 AM
msn.com logoGSK India reports Rs 133 crore net profit
msn.com - May 17 at 1:09 PM
marketbeat.com logoTempus Wealth Planning LLC Invests $679,000 in GSK plc (NYSE:GSK)
marketbeat.com - May 17 at 10:39 AM
forbes.com logoGrabbing GSK For Buy Write Two Days Before It Trades Ex-Dividend
forbes.com - May 16 at 5:06 PM
finance.yahoo.com logoBELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
finance.yahoo.com - May 16 at 5:06 PM
marketbeat.com logoTaika Capital LP Makes New Investment in GSK plc (NYSE:GSK)
marketbeat.com - May 16 at 11:45 AM
seekingalpha.com logoWhat To Expect From GSK In 2023
seekingalpha.com - May 16 at 1:29 AM
proactiveinvestors.com logoGSK: So, just how big is the RSV opportunity? Up to $9bn, says one broker
proactiveinvestors.com - May 15 at 1:31 PM
msn.com logoIf I’d invested £5k in GSK shares one year ago here’s what I’d have today
msn.com - May 15 at 8:31 AM
thetimes.co.uk logoGSK hails court ruling on claim of Zantac cancer link
thetimes.co.uk - May 12 at 8:04 PM
msn.com logoGSK says Canadian court dismisses potential Zantac class suit
msn.com - May 12 at 10:03 AM
MarketBeat logoBrokerages Set GSK plc (NYSE:GSK) Price Target at $1,533.00
americanbankingnews.com - May 12 at 2:38 AM
msn.com logoBRIEF-GSK Announces Intention To Sell Shares In Haleon
msn.com - May 12 at 1:16 AM
markets.businessinsider.com logoGSK To Sell Up To 2.5% Of Haleon's Shares
markets.businessinsider.com - May 12 at 1:16 AM
bloomberg.com logoGSK to Sell $1 Billion Haleon Stake After Consumer Unit Spinoff
bloomberg.com - May 11 at 3:15 PM
news.yahoo.com logoGSK to sell 240 million shares in spin-off firm Haleon
news.yahoo.com - May 11 at 3:15 PM
marketbeat.com logoGSK plc (NYSE:GSK) Shares Bought by Prime Capital Investment Advisors LLC
marketbeat.com - May 11 at 6:50 AM
marketbeat.com logoFORA Capital LLC Reduces Holdings in GSK plc (NYSE:GSK)
marketbeat.com - May 10 at 8:39 AM
marketbeat.com logoGSK plc (NYSE:GSK) Given Consensus Rating of "Hold" by Brokerages
marketbeat.com - May 9 at 3:44 AM
marketbeat.com logoRoanoke Asset Management Corp NY Sells 2,800 Shares of GSK plc (NYSE:GSK)
marketbeat.com - May 8 at 12:22 PM
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:GSK) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -